Skip to content

QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings

QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02570646
Acronym
QA-DDS
Enrollment
248
Registered
2015-10-07
Start date
2015-10-31
Completion date
2016-11-30
Last updated
2019-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use

Brief summary

Using a single-arm trial design, this study will examine the feasibility and acceptability of evaluating QuitAdvisorDDS, a clinical decision support software application designed to facilitate implementation of evidence-based tobacco treatment interventions into the dental setting. The study will examine the feasibility and acceptability of evaluating the impact of the QuitAdvisorDDS tool on patient outcomes related to tobacco use and cessation attempts as well as provider knowledge, attitudes, and practices regarding tobacco treatment. Practitioners (dentists and hygienists) will complete surveys at baseline and follow-up, while patients will complete surveys at baseline and 1-month follow-up. An embedded substudy will also evaluate the feasibility and acceptability of collecting biospecimens (saliva) to serve as biochemical verification of smoking status.

Interventions

BEHAVIORALQA-DDS

QuitAdvisorDDS is a point-of-care software tool to facilitate implementation of evidence-based tobacco treatment interventions in dental care settings.

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
University of Alabama at Birmingham
CollaboratorOTHER
The National Dental Practice-Based Research Network
CollaboratorNETWORK
Health Decision Technologies, LLC
CollaboratorOTHER
Jamie Studts
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Receives dental care from a participating practitioner; * Is age 18 or older; * Self-reports tobacco use within the past month; * Willing to comply with all study procedures and be available for the duration of the study; * Willing to provide verbal informed consent; * Has access to a telephone, and agrees to receive text messages, emails, or telephone calls related to the study. (The patient's preferred method of contact will be ascertained). * Willing to be contacted on a regular basis by each of these entities: the practice;Regional Coordinators (RC) and/or University of Kentucky (UK) researchers; and * Willing to provide contact information of one person living at a different address who will know the patient's whereabouts in the event the patient cannot be reached.

Exclusion criteria

* Psychiatric disability or mental illness judged by the practitioner to be clinically significant so as to preclude informed consent or compliance with procedures of study visits. * Cognitive impairment judged by the practitioner to be significant so as to preclude informed consent or compliance with procedures of study visits.

Design outcomes

Primary

MeasureTime frameDescription
Primary Patient Acceptability A: Rate of Patient Wanting Provider to Use QA-DDSImmediately Post-Consultation up to 1 week80% of participating patients must indicate that they would want their dental practitioner to continue to use QA-DDS.
Primary Patient Feasibility A: Rate of Patient Completion of 1-Month Follow-Up Survey1-Month Follow-Up80% of the enrolled dental care patients must complete the 1-month follow-up survey with the 7-day point prevalence measure of self-reported smoking status.
Primary Patient Acceptability B: Rate of Patient Wanting to Use QA-DDS Patient Portal1-Month Follow-Up80% of participating patients must indicate that they would want to continue to use the QA-DDS Patient Portal.

Secondary

MeasureTime frameDescription
Secondary Patient Acceptability A: Average QA-DDS Satisfaction Ratings Among Patients on 0-10 ScaleImmediately Post-Consultation up to 1 weekAverage QA-DDS satisfaction ratings among enrolled dental patients must be 7 or greater on a 0-10 scale.
Secondary Patient Feasibility A: Rate of Patient Accrual by Study Practices4-Month Follow-Up75% of the study practices must recruit 10 eligible dental patients within a 4-month recruitment phase

Other

MeasureTime frameDescription
Tertiary Patient Acceptability A2: Number of Visits to QA-DDS Patient Portal Per Patient1-Month Follow-UpTo evaluate the acceptability of the QA-DDS Patient Portal among enrolled dental patients, the number of visits to the Patient Portal per patient will be monitored
Tertiary Patient Feasibility A: Rate of Missing Data for Tobacco Use Among Patients1-Month Follow-UpSelf-reported measures of tobacco use and history at the follow-up assessment must have less than 10% missing data among responding dental patients.
Tertiary Patient Acceptability B: Rate of QA-DDS Text Messaging Support Service Use as Measured by Number of Patient Subscriptions1-Month Follow-UpTo evaluate the acceptability of the QA-DDS Text Messaging Support Service, the percentage of enrolled patients who subscribe to the Text Messaging Support Service will be monitored.
Tertiary Patient Acceptability A1: Number of Patients Who Visit QA-DDS Patient Portal1-Month Follow-UpTo evaluate the acceptability of the QA-DDS Patient Portal among enrolled dental patients, the percentage of enrolled patients who make at least one visit to the Patient Portal will be monitored

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026